Home

suuntautuminen kaava Hai resistant tb treatment Samaa mieltä vaha apu

39 Management of drug resistant Tuberculosis Session 01 - YouTube
39 Management of drug resistant Tuberculosis Session 01 - YouTube

Interim treatment outcomes in multidrug-resistant tuberculosis using  bedaquiline and/or delamanid in South Korea - Respiratory Medicine
Interim treatment outcomes in multidrug-resistant tuberculosis using bedaquiline and/or delamanid in South Korea - Respiratory Medicine

Groups of drugs to treat MDR-TB taken from the Treatment of... | Download  Table
Groups of drugs to treat MDR-TB taken from the Treatment of... | Download Table

Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant  Tuberculosis Regimen in a Rural Setting in Angola in: The American Journal  of Tropical Medicine and Hygiene Volume 101 Issue 3 (2019)
Treatment Outcomes and Adverse Events from a Standardized Multidrug-Resistant Tuberculosis Regimen in a Rural Setting in Angola in: The American Journal of Tropical Medicine and Hygiene Volume 101 Issue 3 (2019)

PLOS ONE: Community-based MDR-TB care project improves treatment initiation  in patients diagnosed with MDR-TB in Myanmar
PLOS ONE: Community-based MDR-TB care project improves treatment initiation in patients diagnosed with MDR-TB in Myanmar

Drug-resistant tuberculosis: challenges and opportunities for diagnosis and  treatment - ScienceDirect
Drug-resistant tuberculosis: challenges and opportunities for diagnosis and treatment - ScienceDirect

Efficacy and effect of free treatment on multidrug‑resistant tuberculosis
Efficacy and effect of free treatment on multidrug‑resistant tuberculosis

Tuberculosis treatment: one-shot approach or cascade of regimens? - The  Lancet Respiratory Medicine
Tuberculosis treatment: one-shot approach or cascade of regimens? - The Lancet Respiratory Medicine

Multidrug-resistant tuberculosis (MDR-TB)
Multidrug-resistant tuberculosis (MDR-TB)

Treatment outcomes of multidrug-resistant tuberculosis patients in  Zhejiang, China, 2009–2013 - Clinical Microbiology and Infection
Treatment outcomes of multidrug-resistant tuberculosis patients in Zhejiang, China, 2009–2013 - Clinical Microbiology and Infection

New guide launched for nurses to manage Drug-Resistant Tuberculosis side  effects | ICN - International Council of Nurses
New guide launched for nurses to manage Drug-Resistant Tuberculosis side effects | ICN - International Council of Nurses

Extensively drug-resistant tuberculosis in India: Current evidence on  diagnosis & management Prasad R, Singh A, Balasubramanian V, Gupta N -  Indian J Med Res
Extensively drug-resistant tuberculosis in India: Current evidence on diagnosis & management Prasad R, Singh A, Balasubramanian V, Gupta N - Indian J Med Res

Figure 1 from Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR- TB) Patients to Diagnostic and Treatment Services in Cambodia | Semantic  Scholar
Figure 1 from Linkage of Presumptive Multidrug Resistant Tuberculosis (MDR- TB) Patients to Diagnostic and Treatment Services in Cambodia | Semantic Scholar

Delamanid for Extensively Drug-Resistant Tuberculosis | NEJM
Delamanid for Extensively Drug-Resistant Tuberculosis | NEJM

Predictors of poor treatment outcomes in multidrug-resistant tuberculosis  patients: a retrospective cohort study - Clinical Microbiology and Infection
Predictors of poor treatment outcomes in multidrug-resistant tuberculosis patients: a retrospective cohort study - Clinical Microbiology and Infection

Drug-resistant tuberculosis: what is the situation, what are the needs to  roll it back | AMR Control
Drug-resistant tuberculosis: what is the situation, what are the needs to roll it back | AMR Control

Multidrug-resistant tuberculosis
Multidrug-resistant tuberculosis

Interim treatment outcomes in multidrug-resistant tuberculosis patients  treated sequentially with bedaquiline and delamanid - International Journal  of Infectious Diseases
Interim treatment outcomes in multidrug-resistant tuberculosis patients treated sequentially with bedaquiline and delamanid - International Journal of Infectious Diseases

10.3 Building a treatment regimen for MDR-TB - Tuberculosis
10.3 Building a treatment regimen for MDR-TB - Tuberculosis

XDR-TB treatment outcomes. | Download Table
XDR-TB treatment outcomes. | Download Table

Intermittent treatment interruption and its effect on multidrug resistant  tuberculosis treatment outcome in Ethiopia | Scientific Reports
Intermittent treatment interruption and its effect on multidrug resistant tuberculosis treatment outcome in Ethiopia | Scientific Reports

Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis:  Principles of management Prasad R, Gupta N, Banka A - Lung India
Multidrug-resistant tuberculosis/rifampicin-resistant tuberculosis: Principles of management Prasad R, Gupta N, Banka A - Lung India

Management of multidrug-resistant tuberculosis with shorter treatment  regimen in Niger: Nationwide programmatic achievements - Respiratory  Medicine
Management of multidrug-resistant tuberculosis with shorter treatment regimen in Niger: Nationwide programmatic achievements - Respiratory Medicine

Treatment of isoniazid-resistant tuberculosis with first-line drugs: a  systematic review and meta-analysis - The Lancet Infectious Diseases
Treatment of isoniazid-resistant tuberculosis with first-line drugs: a systematic review and meta-analysis - The Lancet Infectious Diseases

Factors associated with treatment outcome in 64 HIV negative patients with  multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease
Factors associated with treatment outcome in 64 HIV negative patients with multidrug resistant tuberculosis - Ünsal - Journal of Thoracic Disease

Exploring the Threat of MDR-TB in the United States
Exploring the Threat of MDR-TB in the United States

WHO's Rapid Communication on Treatment of Multidrug- and Rifampicin-Resistant  Tuberculosis
WHO's Rapid Communication on Treatment of Multidrug- and Rifampicin-Resistant Tuberculosis